Disease pressure and the overuse of antibiotics are placing significant strain on the livestock and aquaculture sector. Heavy reliance on antibiotics raises concerns around resistance, product safety and long-term sustainability, pushing producers to look for alternatives.

Vietnam Food Joint Stock Company (VNF) approaches this challenge with a biological material rather than conventional antibiotics, aiming to protect animal health while easing the pressure to rely on them. This is the goal behind Nano Chitosan Kito-Super.

Vietnam Food Joint Stock Company (VNF) applies nano chitosan to support immunity and control pathogens

Nano Chitosan Kito-Super is built around several functional properties. As a nano chitosan solution, it supports natural resistance and biological control at once:

• Immune stimulation: nano chitosan supports natural resistance, helping reduce disease incidence and improve animals’ ability to adapt to adverse conditions
• Antibacterial and antifungal action: its poly-amino structure carries many positive charges that interact with the surface of microorganisms, helping inhibit many disease-causing bacteria and fungi
• Nano size, fast action: particles of ≤ 300 nm improve dispersion, delivery and biological activity
• Safe and friendly: chitosan is a biocompatible, non-toxic and environmentally friendly biopolymer, in line with the trend toward reducing antibiotic dependence in modern farming

A biological solution across shrimp, fish and livestock farming

Kito-Super is suitable for shrimp, fish and livestock such as pigs, chickens, ducks and cattle. In use, it helps strengthen immunity and resistance, limit the impact of disease-causing bacteria and fungi, support reductions in stress, swelling and inflammation, improve growth and the feed conversion ratio, and raise farming efficiency in a safe, sustainable direction.

By helping producers proactively protect animal health, reduce the pressure to use antibiotics and optimise production efficiency, Nano Chitosan Kito-Super from Vietnam Food Joint Stock Company (VNF) reflects a wider shift toward biological, antibiotic-reducing solutions in modern livestock and aquaculture.